Abstract
Using two cholecystokinin (CCK) radioimmunoassays CCK has been shown to be heterogeneous (CCK-33 and CCK-8) after both exogenous infusion and endogenous release. CCK-39 (CCK variant) was not separated after endogenous CCK stimulation but was identified after the exogenous infusion of 16% pure CCK. The disappearance half-time of 16% pure CCK has been shown to be 2.4 min and one major organ of catabolism identified--the kidney. Degradation of CCK by whole blood occurred after standing for 2 h, but if separation was carried out immediately serum could be left for 6 h before any further degradation took place. Serum appeared to retain its CCK activity more reliably than plasma. Abnormalities in CCK release in duodenal ulcer disease, which are further altered by highly selective vagotomy (HSV), have been demonstrated. Pancreatic exocrine function was not significantly altered by HSV. CCK release and disappearance are more rapid in patients with duodenal ulceration. This observation may be aetiologically important since unopposed postprandial hypergastrinaemia in the absence of effective inhibition by CCK might lead to increased gastric acid production.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Berry H., Flower R. J. The assay of endogenous cholecystokinin and factors influencing its release in the dog and cat. Gastroenterology. 1971 Mar;60(3):409–420. [PubMed] [Google Scholar]
- Clendinnen B. G., Davidson W. D., Reeder D. D., Jackson B. M., Thompson J. C. Renal uptake and excretion of gastrin in the dog. Surg Gynecol Obstet. 1971 Jun;132(6):1039–1043. [PubMed] [Google Scholar]
- Grossman M. I. Gastrin, cholecystokinin, and secretin act on one receptor. Lancet. 1970 May 23;1(7656):1088–1089. doi: 10.1016/s0140-6736(70)92758-3. [DOI] [PubMed] [Google Scholar]
- Harper A. A., Raper H. S. Pancreozymin, a stimulant of the secretion of pancreatic enzymes in extracts of the small intestine. J Physiol. 1943 Jun 30;102(1):115–125. doi: 10.1113/jphysiol.1943.sp004021. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Harvey R. F., Dowsett L., Hartog M., Read A. E. Radioimmunoassay of cholecystokinin-pancreozymin. Gut. 1974 Sep;15(9):690–699. doi: 10.1136/gut.15.9.690. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Harvey R. F., Oliver J. M. Hormonal content and effect on gallbladder of commercial preparations of cholecystokinin-pancreozymin. Horm Metab Res. 1981 Aug;13(8):446–450. doi: 10.1055/s-2007-1019297. [DOI] [PubMed] [Google Scholar]
- Konturek S. J., Obtułowicz W., Kwiecień N., Sito E., Oleksy J., Miszczuk-Jamska B. Effect of ranitidine, a new H2-antagonist, on gastric and pancreatic secretion in duodenal ulcer patients. Dig Dis Sci. 1980 Oct;25(10):737–743. doi: 10.1007/BF01345291. [DOI] [PubMed] [Google Scholar]
- Lavigne M. E., Wiley Z. D., Martin P., Way L. W., Meyer J. H., Sleisenger M. H., MacGregor I. L. Gastric, pancreatic, and biliary secretion and the rate of gastric emptying after parietal cell vagotomy. Am J Surg. 1979 Nov;138(5):644–651. doi: 10.1016/0002-9610(79)90337-4. [DOI] [PubMed] [Google Scholar]
- Rabkin R., Colwell J. A. The renal uptake and excretion of insulin in the dog. J Lab Clin Med. 1969 Jun;73(6):893–900. [PubMed] [Google Scholar]
- Thompson J. C., Reeder D. D., Bunchman H. H., Becker H. D., Brandt E. N., Jr Effect of secretin on circulating gastrin. Ann Surg. 1972 Sep;176(3):384–393. doi: 10.1097/00000658-197209000-00014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Walsh J. H., Debas H. T., Grossman M. I. Pure human big gastrin. Immunochemical properties, disappearance half time, and acid-stimulating action in dogs. J Clin Invest. 1974 Aug;54(2):477–485. doi: 10.1172/JCI107783. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wiggins H. S. Simple method for estimating trypsin. Gut. 1967 Aug;8(4):415–416. doi: 10.1136/gut.8.4.415. [DOI] [PMC free article] [PubMed] [Google Scholar]